Chapter XVII FINAL PROVISIONS

United Kingdom

1. 80Fees and charges
2. 81The competent authority
3. 82Committee procedure
4. 83Exercise of the delegation
5. 83ARegulation procedure
6. 83BThe consent requirement
7. 84Urgency procedure
8. 85Adaptation to scientific and technical progress
9. 86Active substances included in Annex I to Directive 98/8/EC
10. 87Penalties
11. 88Safeguard clause
12. 89Existing transitional measures
13. 90Transitional measures concerning active substances evaluated under Directive 98/8/EC
14. 91Transitional measures concerning applications for biocidal product authorisations submitted under Directive 98/8/EC
15. 92Transitional measures concerning biocidal products authorised/registered under Directive 98/8/EC
16. 93Transitional measures concerning biocidal products not covered by the scope of Directive 98/8/EC
17. 94Transitional measures concerning treated articles
18. 95Transitional measures concerning access to the active substance dossier
19. 95ATransitional measures for simplified notification procedure
20. 95BTransitional measures for mutual recognition applications
21. 95CRenewal of authorisations subject to mutual recognition under Regulation 492/2014
22. 95DTransitional measure for national authorisation applications
23. 95ETransitional measures simplified authorisation applications
24. 95FTransitional measures for applications for same biocidal product authorisations
25. 95FATransitional measures for applications for same biocidal product authorisations under the simplified procedure
26. 95GTransitional measures for Regulation (EU) No 528/2012 authorisations
27. 95HTransitional measures for ongoing applications for Union authorisations
28. 95ITransitional measures for Article 95 List
29. 95JTransitional measure for active substance applications made to the United Kingdom competent authority before 30 March 2019 and subsequently reallocated
30. 95KTransitional measure for active substance applications made before IP completion day pursuant to Article 93 where the United Kingdom competent authority was not the evaluating competent authority
31. 95LTransitional measures for renewal of an approval of an active substance
32. 95MTransitional measures for ongoing applications to change or amend authorisations
33. 95NInterpretation of Articles 95A to 95M
34. 96Repeal
35. 97Entry into force